First Look Analysts Research Calls for Wednesday, March 1
This report was sent to Briefing.com subscribers earlier today. Upgrades: > Coupang (CPNG) upgraded to Buy from Hold at Deutsche Bank; tgt $20 > Empire State Realty Trust (ESRT) upgraded to Buy from Neutral at BofA Securities; tgt $9.25 >…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Coupang (CPNG) upgraded to Buy from Hold at Deutsche Bank; tgt $20
> Empire State Realty Trust (ESRT) upgraded to Buy from Neutral at BofA Securities; tgt $9.25
> Interface (TILE) upgraded to Buy from Neutral at Longbow; tgt $18
> Sarepta Therapeutics (SRPT) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $187
> TransUnion (TRU) upgraded to Outperform from Neutral at Exane BNP Paribas; tgt $80
Downgrades:
> Builders FirstSource (BLDR) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt raised to $92
> Eni S.p.A. (E) downgraded to Neutral from Outperform at Exane BNP Paribas
> Spirit Aerosystems (SPR) downgraded to Mkt Perform from Outperform at Bernstein; tgt lowered to $38
Others:
> AbbVie (ABBV) initiated with a Buy at Guggenheim; tgt $172
> Aerovate Therapeutics (AVTE) initiated with a Buy at Guggenheim; tgt $36
> ANI Pharma (ANIP) initiated with a Buy at Guggenheim; tgt $55
> Calliditas Therapeutics AB (CALT) initiated with a Neutral at Guggenheim; tgt $18
> Chinook Therapeutics (KDNY) initiated with a Buy at Guggenheim; tgt $43
> Columbia Banking (COLB) initiated with an Overweight at Wells Fargo; tgt $37
> Gossamer Bio (GOSS) initiated with a Neutral at Guggenheim
> Johnson & Johnson (JNJ) initiated with a Neutral at Guggenheim; tgt $161
> Travere Therapeutics (TVTX) initiated with a Buy at Guggenheim; tgt $37
Contact [email protected] for any questions or corrections.